New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2013
08:07 EDTGHDXGenomic Health announces positive results of Oncotype DX in colon cancer
Genomic Health announced results from three studies of the Oncotype DX Colon Cancer test at the 2013 Gastrointestinal Cancers Symposium, including new data demonstrating that Recurrence Score results changed treatment recommendations in 45% of the enrolled stage II colon cancer patients. Presentations also include positive findings from a second health economics analysis suggesting that use of the test may result in a significant reduction in direct medical costs and improve patient well-being.
News For GHDX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 19, 2014
10:17 EDTGHDXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:15 EDTGHDXGenomic Health initiated with a Market Perform at Wells Fargo
Price target range $33-$35.
December 18, 2014
08:05 EDTGHDXGenomic Health apoints Patrick F. Terry as Chief Commercial Officer
Claritas Genomics appointed Patrick F. Terry to the role of Chief Commercial Officer. Terry has been involved in shepherding multiple biotechnology products through commercial development to clinical delivery.
December 10, 2014
08:06 EDTGHDXGenomic Health presents first results of Oncotype DX breast cancer test
Subscribe for More Information
December 9, 2014
09:03 EDTGHDXGenomic Health advances development of novel liquid biopsy-based cancer tests
Subscribe for More Information
December 8, 2014
07:26 EDTGHDXLeerink to hold a tour
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use